Post-approval studies (Phase 4)Study completedNCT00148759What this trial is testingKaletra Sex/Gender Pharmacokinetics (PK) StudyWho this might be right forHIV Infections Emory University 23
Post-approval studies (Phase 4)UnknownNCT04350684What this trial is testingUmifenovir in Hospitalized COVID-19 PatientsWho this might be right forCOVID-19 Shahid Beheshti University of Medical Sciences 40
Early research (Phase 1)Study completedNCT00697892What this trial is testingPharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug CombinationsWho this might be right forHIV InfectionsMalaria Fran Aweeka 38
Testing effectiveness (Phase 2)Study completedNCT00075231What this trial is testingA Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected SubjectsWho this might be right forHIV Infections Abbott 150
Post-approval studies (Phase 4)Ended earlyNCT01031849What this trial is testingAnalysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / RitonavirWho this might be right forHIV Infections Ines Perez 7
Large-scale testing (Phase 3)Ended earlyNCT00144833What this trial is testingOpen Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV SubjectsWho this might be right forHIV-1 GlaxoSmithKline 150
Post-approval studies (Phase 4)Study completedNCT00810108What this trial is testingLopinavir/Ritonavir (Kaletra) PK in ChildrenWho this might be right forHIV/AIDS TreatmentHIV Infections Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 12
Testing effectiveness (Phase 2)Study completedNCT02415985What this trial is testingPharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice WeeklyWho this might be right forHIVTuberculosis The HIV Netherlands Australia Thailand Research Collaboration 40
Post-approval studies (Phase 4)Ended earlyNCT00981318What this trial is testingPilot Assessment of Lopinavir/Ritonavir and MaravirocWho this might be right forHIV InfectionsAcquired Immunodeficiency Syndrome Rodwick, Barry M., M.D. 3
Large-scale testing (Phase 3)Study completedNCT00234910What this trial is testingEfficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected PatientsWho this might be right forHIV Infection Abbott 152
Large-scale testing (Phase 3)UnknownNCT00025727What this trial is testingComparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological FailureWho this might be right forHIV Infections GlaxoSmithKline 330
Not applicableStudy completedNCT00357552What this trial is testingSafety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV TherapyWho this might be right forHIV Infections Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 123
Post-approval studies (Phase 4)Ended earlyNCT00234962What this trial is testingStudy of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral TherapyWho this might be right forHIV Infection Abbott 200
Testing effectiveness (Phase 2)UnknownNCT01663168What this trial is testingEARNEST Rifabutin Pharmacokinetics (PK) SubstudyWho this might be right forHIVTuberculosis Justine Boles 140
Not applicableLooking for participantsNCT03603977What this trial is testingSimplified Treatment of Anti-retrovirus in China (C-STAR)Who this might be right forHIV/AIDS Guangzhou 8th People's Hospital 600
Large-scale testing (Phase 3)Study completedNCT02227238What this trial is testingComparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line TreatmentWho this might be right forHIV Infections ViiV Healthcare 627
Early research (Phase 1)UnknownNCT01259219What this trial is testingDosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With KaletraWho this might be right forChildren With Confirmed HIV InfectionReceiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard DoseSuccessfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment Harriet Shezi Children's Clinic 40
Not applicableStudy completedNCT01383005What this trial is testingTreatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)Who this might be right forHuman Immunodeficiency Virus Infection AbbVie (prior sponsor, Abbott) 97
Large-scale testing (Phase 3)Study completedNCT00140751What this trial is testingComparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected PatientsWho this might be right forHIV Infections Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 186
Large-scale testing (Phase 3)Study completedNCT00358917What this trial is testingStudy of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected SubjectsWho this might be right forHuman Immunodeficiency Virus Infections Abbott 599